Use of V-Go^® Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes System.

ABSTRACT:

Introduction

Tight glycemic control and timely treatment can improve outcomes in patients with diabetes yet many remain sub-optimally controlled. The objective of the current study was to evaluate the effect of switching patients with sub-optimally controlled diabetes to the V-Go^® (Valeritas Inc., Bridgewater, NJ, USA) Disposable Insulin Delivery device.

Methods

A retrospective analysis of electronic medical records was conducted to assess patients with sub-optimal glycemic control defined as a glycated hemoglobin (HbA1c) >7%, switched to V-Go. Blood glucose control defined as change from baseline in HbA1c, prescribed insulin doses, body weight, concomitant anti-hyperglycemic agents, and reported hypoglycemia were collected prior to switching to V-Go and during V-

SUBMITTER: Lajara R 

PROVIDER: S-EPMC4674471 | biostudies-literature | 2015 Dec

REPOSITORIES: biostudies-literature